Atrial fibrillation (AF), the most commonly encoun-tered arrhythmia in clinical practice, is associated with a 2-fold increase in total cardiovascular mortality[1], as well as the potential for substantial morbidity, including stroke, congestive heart failure, and cardiomyopathy. Its incidence and prevalence are increasing, and it representsa growing clinical and economic burden. Owing to rela-tive inefficacy and
展开▼
机译:Appropriate Selection of Oral Anticoagulant (OAC) Therapy for Stroke Prevention Among Older Subjects with Atrial Fibrillation (AF) Has Improved Over Time but an Evidence Treatment Gap Persists